Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1999
11/18/1999WO1999037803A9 INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53
11/18/1999WO1999036094A3 Composition and method for treating metastatic tumors or cancer induced by cells expressing sv40 tumor antigen
11/18/1999WO1999033980A3 Members of tnf and tnfr families
11/18/1999WO1999028475A3 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/18/1999WO1999028349A3 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
11/18/1999WO1999027098A3 A-33 related antigens and their pharmacological uses
11/18/1999DE19826444C1 DNA encoding a spinach glucose translocator, plasmids, bacteria, yeast and transformed plant cells
11/18/1999DE19821866A1 Catalyzing complex reactions of large molecules, especially insulin production from preproinsulin, using immobilized enzymes
11/18/1999CA2685270A1 Expression vectors for stimulating an immune response and methods of using the same
11/18/1999CA2404693A1 97 human secreted proteins
11/18/1999CA2332109A1 97 human secreted proteins
11/18/1999CA2331853A1 Recombinant baculovirus-based insecticides
11/18/1999CA2331754A1 Methods of determining protein activity levels using gene expression profiles
11/18/1999CA2331455A1 Novel molecule and diagnosis method
11/18/1999CA2331061A1 Complex formed by a peptide and a major histocompatibility complex at the surface of phages
11/18/1999CA2330000A1 Diagnosis and treatment of hepatic disorders
11/18/1999CA2328520A1 Use of anti-prolactin agents to treat proliferative conditions
11/18/1999CA2328502A1 Cloning of basb020 antigen from moraxella catarrhalis
11/18/1999CA2328493A1 Transgenic plant-derived human blood coagulation factors
11/18/1999CA2328490A1 Fused protein
11/18/1999CA2328481A1 Methods and compositions for screening for modulators of ige synthesis, secretion and switch rearrangement
11/18/1999CA2328429A1 Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis
11/18/1999CA2328405A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene
11/18/1999CA2328403A1 Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis
11/18/1999CA2328397A1 Human antithrombin iiis and methods related thereto
11/18/1999CA2328141A1 Compounds from moraxella catarrhalis
11/18/1999CA2328131A1 Method for producing plants having an increased tolerance against drought and/or fungal attack and/or increased salt concentrations and/or extreme temperature by the expression ofplasmodesmata-localized proteins
11/18/1999CA2328130A1 Moraxella catarrhalis proteins
11/18/1999CA2328062A1 Secreted proteins and polynucleotides encoding them
11/18/1999CA2328061A1 Novel compounds
11/18/1999CA2327549A1 Peptides that induce t cell responses
11/18/1999CA2327548A1 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors
11/18/1999CA2327546A1 Transgenic plant cells expressing a recombinant plant e2f peptide
11/18/1999CA2327523A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use
11/18/1999CA2327354A1 Human apoptosis associated proteins
11/18/1999CA2327351A1 Cell signaling proteins
11/18/1999CA2327265A1 Zea mays phosphate transporter genes and uses thereof
11/18/1999CA2324206A1 Prostapin gene and protein and uses thereof
11/17/1999EP0957362A2 Dye-labeled protein conjugate and method for preparing the same
11/17/1999EP0957172A2 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
11/17/1999EP0957167A1 Production of heterodimeric human fertility hormones
11/17/1999EP0957166A1 HUMANIZED IMMUNOGLOBULIN REACTING SPECIFICALLY WITH Fas LIGAND OR ACTIVE FRAGMENTS THEREOF AND REGION INDUCING APOPTOSIS ORIGINATING IN Fas LIGAND
11/17/1999EP0957165A2 Optimizing cells for endogenous gene activation
11/17/1999EP0957164A1 Insulin binding polypeptide
11/17/1999EP0957162A1 Biological viral material obtained from a multiple sclerosis-associated virus strain infected cell line
11/17/1999EP0957110A2 Lyophilized tubulins
11/17/1999EP0957093A2 Retrovial protease inhibitors
11/17/1999EP0956862A1 Methods of increasing lean tissue mass using ob protein compositions
11/17/1999EP0956508A1 Icam-4 and diagnostic uses thereof
11/17/1999EP0956360A1 Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses
11/17/1999EP0956359A1 High fidelity detection of nucleic acid differences by ligase detection reaction
11/17/1999EP0956358A2 Cd95 regulatory gene sequences and transcription factors
11/17/1999EP0956357A1 Invertase inhibitor
11/17/1999EP0956355A2 Method for immortalizing cells
11/17/1999EP0956352A1 A polynucleotide herpes virus vaccine
11/17/1999EP0956351A1 A tumor necrosis factor related ligand
11/17/1999EP0956350A1 Human chloride channel protein (hccp)
11/17/1999EP0956349A1 Synthetic hpv16 virus-like particles
11/17/1999EP0956343A1 Recombinant swinepox virus
11/17/1999EP0956342A1 Methods for identifying vasoprotective agents
11/17/1999EP0956339A1 Recombinant vascular endothelial cell growth factor d (vegf-d)
11/17/1999EP0956303A2 Non-naturally occurring lipoprotein particle
11/17/1999EP0956302A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes
11/17/1999EP0956301A2 Il-12 gene expression and delivery systems and uses
11/17/1999EP0956300A1 Adenoviral vectors for mutants of human interleukin 6 (hil-6) with hil-6 antagonist activity, pharmaceutical compositions therewith and their uses
11/17/1999EP0956299A1 Peptide antagonists of dp transcription factors
11/17/1999EP0956298A1 Snrnp sm proteins
11/17/1999EP0956297A1 Chiral peptide nucleic acids
11/17/1999EP0956296A2 Somatostatin antagonists
11/17/1999EP0956292A1 Conantokins
11/17/1999EP0956291A1 Dna encoding galanin galr3 receptors and uses thereof
11/17/1999EP0956290A1 Gp120 polypeptides having conformational discontinuous chemokine receptor binding sites and methods of inhibiting hiv infection
11/17/1999EP0956289A1 Novel prokaryotic polynucleotides, polypeptides and their uses
11/17/1999EP0956155A1 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution
11/17/1999EP0956052A1 Chimeric retrovirus/adenovirus system
11/17/1999EP0956049A2 Conjugates of thrombin inhibitors and endogenes carriers
11/17/1999EP0956044A1 Uses of a chemokine receptor for inhibiting hiv-1 infection
11/17/1999EP0956043A1 Strain selection of pneumococcal surface proteins
11/17/1999EP0956039A1 A method of treatment and prophylaxis
11/17/1999EP0956038A1 Morphogen peptide-induced regeneration of sense perceptory tissues
11/17/1999EP0956036A1 Anti-fibrotic agent assay
11/17/1999EP0956032A1 Proteins and compositions for modulating mitosis
11/17/1999EP0956030A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells
11/17/1999EP0955808A1 Human g-protein coupled receptor
11/17/1999EP0955807A1 Dna and encoded protein which regulates cold and dehydration regulated genes
11/17/1999EP0955804A1 Expression of globin proteins in plants
11/17/1999EP0955803A1 Plant retroviral polynucleotides and methods for use thereof
11/17/1999EP0830509A4 Polymers responsive to electrical energy
11/17/1999EP0804576A4 A novel haemopoietin receptor
11/17/1999EP0707660A4 Method for generation of sequence sampled maps of complex genomes
11/17/1999EP0651762B1 Method and apparatus for the rapid synthesis of substrate-bound or free peptides or oligonucleotides, flat material synthesized in this way and the use of such material
11/17/1999EP0604566B1 Chimeric and/or growth-restricted flaviviruses
11/17/1999CN1235635A Extracellent expression of cellulose binding domains (CBD) using bacillus
11/17/1999CN1235611A Use of glucagon-like peptide-1 (GLP-1) or analogs to abolish catabolic changes after surgery
11/17/1999CN1235609A Immunostimulatory nucleic acid molecules
11/17/1999CN1235594A Methods and compositions for lipidization of hydrophilic molecules
11/17/1999CN1235555A Compounds and methods for treatment and diagnosis of mycobacterial infections
11/17/1999CN1235513A Nucleic acid and amino acid sequences ralating to helicobacter pylori and vaccine compositions thereof
11/17/1999CN1235164A Peptide for vaccine of schistosomiasis
11/17/1999CN1235163A Peptide for vaccine of schistosomiasis
1 ... 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 ... 2916